GOLDMAN SACHS GROUP INC - RANI THERAPEUTICS HLDGS INC ownership

RANI THERAPEUTICS HLDGS INC's ticker is and the CUSIP is 753018100. A total of 23 filers reported holding RANI THERAPEUTICS HLDGS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of RANI THERAPEUTICS HLDGS INC
ValueSharesWeighting
Q1 2023$173,025
+55.9%
33,532
+212.2%
0.00%
Q2 2022$111,000
-69.3%
10,739
-60.0%
0.00%
Q1 2022$362,000
-66.5%
26,820
-55.8%
0.00%
Q3 2021$1,081,00060,6490.00%
Other shareholders
RANI THERAPEUTICS HLDGS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Nan Fung Group Holdings Ltd 493,584$2,033,5661.30%
LASRY MARC 62,887$259,0940.34%
Alpha Square Group S LLC 101,573$418,4810.30%
Alphabet Inc. 448,492$1,847,7870.10%
UNITED SERVICES AUTOMOBILE ASSOCIATION 481,300$1,944,4520.06%
ISLAY CAPITAL MANAGEMENT, LLC 9,611$39,5970.04%
Lafayette Investments 19,893$81,9600.02%
MOTCO 48,129$198,2910.01%
CHOREO, LLC 19,813$81,6300.00%
HRT FINANCIAL LP 41,342$1700.00%
View complete list of RANI THERAPEUTICS HLDGS INC shareholders